173 related articles for article (PubMed ID: 8540763)
1. Effects of serotoninergic agents on downregulation of beta-adrenoceptors by the selective serotonin reuptake inhibitor sertraline.
Koe BK; Lebel LA
Arch Int Pharmacodyn Ther; 1995; 329(2):231-44. PubMed ID: 8540763
[TBL] [Abstract][Full Text] [Related]
2. Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.
Koe BK; Koch SW; Lebel LA; Minor KW; Page MG
Eur J Pharmacol; 1987 Sep; 141(2):187-94. PubMed ID: 2824215
[TBL] [Abstract][Full Text] [Related]
3. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo.
Rollema H; Clarke T; Sprouse JS; Schulz DW
J Neurochem; 1996 Nov; 67(5):2204-7. PubMed ID: 8863532
[TBL] [Abstract][Full Text] [Related]
4. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
7. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Kind B; Fattinger K; Krähenbühl S; Meier-Abt PJ
Praxis (Bern 1994); 1996 Nov; 85(46):1490-2. PubMed ID: 8984572
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
9. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
Darmani NA; Reeves SL
Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Stenfors C; Yu H; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
[TBL] [Abstract][Full Text] [Related]
11. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
[TBL] [Abstract][Full Text] [Related]
12. Role of serotonin receptors in the effect of sertraline on feeding behaviour.
Grignaschi G; Samanin R
Psychopharmacology (Berl); 1993; 110(1-2):203-8. PubMed ID: 7870886
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
[TBL] [Abstract][Full Text] [Related]
14. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
Koe BK; Weissman A; Welch WM; Browne RG
J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
[TBL] [Abstract][Full Text] [Related]
15. Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.
Cryan JF; McGrath C; Leonard BE; Norman TR
Pharmacol Biochem Behav; 1999 Jun; 63(2):333-8. PubMed ID: 10371664
[TBL] [Abstract][Full Text] [Related]
16. Behavioral stimulation without alteration of beta and 5-HT receptors and adenylate cyclase activity in rat brain after chronic sertraline administration.
Tadokoro C; Kiuchi Y; Yamazaki Y; Nara K; Oguchi K; Kamijima K
Psychopharmacology (Berl); 1997 Mar; 130(2):124-30. PubMed ID: 9106909
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
18. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
[TBL] [Abstract][Full Text] [Related]
19. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis.
Moret C; Briley M
J Neural Transm (Vienna); 1997; 104(2-3):147-60. PubMed ID: 9203078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
